SMIPX | VIMSX | SMIPX / VIMSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 26 years | - |
Gain YTD | 14.189 | 12.557 | 113% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000 | 8% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13M | 172B | 0% |
Annual Yield % from dividends | 0.00 | 1.38 | - |
Returns for 1 year | 29.65 | 25.11 | 118% |
Returns for 3 years | 6.01 | 9.82 | 61% |
Returns for 5 years | 27.85 | 56.75 | 49% |
Returns for 10 years | 1.82 | 128.21 | 1% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FEKFX | 16.32 | 0.02 | +0.12% |
Fidelity Equity-Income K6 | |||
FIJYX | 37.59 | -0.06 | -0.16% |
Fidelity Advisor Biotechnology Z | |||
PLFSX | 28.25 | -0.06 | -0.21% |
Principal Large Cap S&P 500 Index R4 | |||
AGYGX | 13.27 | -0.05 | -0.38% |
American Century Focused Global Gr Y | |||
SSCDX | 17.54 | -0.10 | -0.57% |
Sit Small Cap Dividend Growth I |